Skip to content

Opening book details…

About this Medicine article

How much should LDL cholesterol be lowered in secondary prevention? Clinical efficacy and safety in the era of PCSK9 inhibitors by Cybulska, Barbara ;Kłosiewicz-Latoszek, Longina ;Penson, Peter E. ;Nabavi, Seyed Mohammad ;Lavie, Carl J. ;Banach, Maciej is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Cybulska, Barbara ;Kłosiewicz-Latoszek, Longina ;Penson, Peter E. ;Nabavi, Seyed Mohammad ;Lavie, Carl J. ;Banach, Maciej
Publisher
Elsevier BV
Published
2020
Field
Medicine (Health Sciences)

More by Cybulska, Barbara ;Kłosiewicz-Latoszek, Longina ;Penson, Peter E. ;Nabavi, Seyed Mohammad ;Lavie, Carl J. ;Banach, Maciej

Browse all works by Cybulska, Barbara ;Kłosiewicz-Latoszek, Longina ;Penson, Peter E. ;Nabavi, Seyed Mohammad ;Lavie, Carl J. ;Banach, Maciej